ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2021; 12(22):6600-6609. doi:10.7150/jca.60724 This issue Cite
Research Paper
MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer
1. Department of Oncology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
2. Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen 518020, China.
3. Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
4. Department of Medical Imaging, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
#These authors contributed equally to this work.
Citation:
Zhao M, Tang Z, Wang Y, Ding J, Guo Y, Zhang N, Gao T. MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer. J Cancer 2021; 12(22):6600-6609. doi:10.7150/jca.60724. https://www.jcancer.org/v12p6600.htm
Other stylesAbstract
Lung cancer is a serious threat to human health due to its high morbidity and mortality. microRNAs (miRNAs) are involved in the tumorigenesis and progression of lung cancer. In this study, we elucidated the role of miRNA-4507 (miR-4507) in the pathogenesis of non‐small‐cell lung cancer (NSCLC). miR-4507 is found to be upregulated in NSCLC cells (A549, H460). MTT, 5-ethynyl-2'-deoxyuridine (EdU), wound healing, and transwell assays were performed to evaluate NSCLC cell proliferation and migration. The results demonstrated that miR-4507 inhibition significantly decrease the proliferation and migration of NSCLC cells. Subsequently, a luciferase activity assay was conducted to verify the regulation of the predicted gene target of miR-4507, namely, TP53. Mechanism experiments show that miR-4507 activates the PI3K/AKT signal. Further, we co-transfected miR-4507 mimics and TP53 plasmids and found that TP53 overexpression could recover the effects of miR-4507 mimics on proliferation, migration, and the PI3K/AKT signal activation. These results suggested that miR-4507 targets TP53 to facilitate the proliferation and migration of lung cancer cells through PI3K/AKT signal and that miR-4507 could serve as a potential target for NSCLC treatment.
Keywords: miR-4507, migration, non‐small‐cell lung cancer, proliferation, TP53
Citation styles
APA
Zhao, M., Tang, Z., Wang, Y., Ding, J., Guo, Y., Zhang, N., Gao, T. (2021). MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer. Journal of Cancer, 12(22), 6600-6609. https://doi.org/10.7150/jca.60724.
ACS
Zhao, M.; Tang, Z.; Wang, Y.; Ding, J.; Guo, Y.; Zhang, N.; Gao, T. MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer. J. Cancer 2021, 12 (22), 6600-6609. DOI: 10.7150/jca.60724.
NLM
Zhao M, Tang Z, Wang Y, Ding J, Guo Y, Zhang N, Gao T. MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer. J Cancer 2021; 12(22):6600-6609. doi:10.7150/jca.60724. https://www.jcancer.org/v12p6600.htm
CSE
Zhao M, Tang Z, Wang Y, Ding J, Guo Y, Zhang N, Gao T. 2021. MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non‐small‐cell Lung Cancer. J Cancer. 12(22):6600-6609.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.